Industry News
AnteoTech’s AnteoBind™ technology supports first-of-its-kind COVID-19 Home Test
Funding of $231.8 million U.S. awarded to Ellume COVID-19 Home Test that integrates AnteoBind™ for superior sensitivity
Funding of $231.8 million U.S. awarded to Ellume COVID-19 Home Test that integrates AnteoBind™ for superior sensitivity
AnteoTech Ltd has successfully developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests that can detect the presence of SARS-Cov-2 and influenza in less than 15 minutes